EZH2 and prostate cancer: Genetic and epigenetic modulators can crosstalk and promote cellular plasticity; for instance, in prostate cancer, TP53 and RB1 loss can cause upregulation of SOX2 and EZH2 [156,188] and consequently an epigenetically permissive state facilitating lineage plasticity.